Orchestra BioMed Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	113	152	326	112	206	262
Market Cap Growth	-13.03%	-53.41%	191.65%	-45.72%	-21.31%	-
Enterprise Value	79	87	229	193	-	-
Last Close Price	2.94	4.00	9.13	9.98	10.08	12.81
PS Ratio	38.14	57.64	118.24	31.67	-263.60	45.94
PB Ratio	6.68	4.61	4.80	2.13	-10.42	90.02
P/TBV Ratio	6.68	4.61	4.80	2.13	-	-
EV/Sales Ratio	27.44	32.97	82.96	54.51	-	-
Debt / Equity Ratio	0.98	0.50	0.03	0.23	-0.29	3.25
Asset Turnover	0.04	0.03	0.03	0.07	-	-
Inventory Turnover	1.71	1.28	0.88	1.23	2.91	-
Quick Ratio	3.23	4.13	7.82	4.52	0.90	2.50
Current Ratio	3.35	4.27	7.95	4.56	0.93	2.52
Return on Equity (ROE)	-179.12%	-120.84%	-81.47%	-205.22%	-	-
Return on Assets (ROA)	-60.70%	-46.90%	-33.75%	-37.42%	-52.79%	-
Return on Capital (ROIC)	-93.36%	-67.42%	-48.00%	-81.16%	-	-
Earnings Yield	-58.87%	-40.13%	-15.05%	-30.04%	-11.16%	-8.15%
FCF Yield	-48.34%	-33.44%	-14.16%	-26.70%	-9.56%	-10.20%
Buyback Yield / Dilution	-6.17%	-10.82%	-121.67%	-609.97%	-4.86%	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q